{"version":"1.0","provider_name":"TwoKnct Media &amp; Publishing ","provider_url":"https:\/\/twoknctmedia.com","author_name":"admin","author_url":"https:\/\/twoknctmedia.com\/index.php\/author\/admin_8skkymeb\/","title":"In Vivo Gene Editing: From Bench to Bedside - TwoKnct Media &amp; Publishing","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"cVBQ2O9efl\"><a href=\"https:\/\/twoknctmedia.com\/index.php\/2025\/06\/19\/in-vivo-gene-editing-from-bench-to-bedside\/\">In Vivo Gene Editing: From Bench to Bedside<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/twoknctmedia.com\/index.php\/2025\/06\/19\/in-vivo-gene-editing-from-bench-to-bedside\/embed\/#?secret=cVBQ2O9efl\" width=\"600\" height=\"338\" title=\"&#8220;In Vivo Gene Editing: From Bench to Bedside&#8221; &#8212; TwoKnct Media &amp; Publishing \" data-secret=\"cVBQ2O9efl\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/twoknctmedia.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/twoknctmedia.com\/wp-content\/uploads\/2025\/06\/In-Vivo-Gene-Editing-From-Bench-to-Bedside.png","thumbnail_width":512,"thumbnail_height":288,"description":"In Vivo Gene Editing: From Bench to Bedside Welcome to the In Vivo Gene Editing Conference 2026\u00a0\u2014 a premier global gathering of scientists, clinicians, and innovators advancing the real-world application of gene editing. Over two immersive days, we explore the path from cutting-edge bench research to clinical translation and therapeutic impact. Join us in Barcelona to collaborate, catalyze innovation, and shape the future of gene editing. ENQUIRE NOW +420 776 164 009 (Prague office) info@twoknctmedia.com January 29th-30th 2026 Barcelona, Spain Registration Conference Introduction Welcome to the In Vivo Gene Editing Conference 2026\u00a0\u2014 a premier global gathering of scientists, clinicians, and innovators advancing the real-world application of gene editing. Over two immersive days, we explore the path from cutting-edge bench research to clinical translation and therapeutic impact. Join us in Barcelona to collaborate, catalyze innovation, and shape the future of gene editing. 6 Key Themes for the Gene Editing Conference 2026 CRISPR and Beyond: Editing Technologies: Advances in CRISPR-Cas, base editing, prime editing, and novel platforms. Delivery Systems for In Vivo Editing: Viral and non-viral vectors, tissue targeting, and immunogenicity challenges.\u00a0 Therapeutic Applications: Treating genetic, metabolic, and acquired diseases via in vivo editing.\u00a0 Manufacturing &amp; Scalability: GMP production of editors and vectors, scalability for clinical use.\u00a0 Regulatory Pathways &amp; Safety: Clinical trial design, long-term monitoring, and regulatory updates.\u00a0 Ethics, Access &amp; Global Equity: Ethical frameworks, equitable access, and implementation in LMICs. Who Should Attend Who Should Attend Researchers &amp; Scientists: Experts in genome engineering, delivery, and disease biology. Biotech &amp; Pharma Professionals: Involved in R&amp;D, manufacturing, translational medicine, and regulatory strategy. Investors &amp; Venture Capitalists: Exploring the next wave of gene editing innovation. Clinicians &amp; Geneticists Focused on therapeutic adoption and patient outcomes. Policy Makers &amp; Bioethicists Guiding approval pathways and public trust in gene technologies. Global Health Organizations &amp; NGOs Advocating for equitable access and infrastructure Industries Represented Gene Therapy &amp; Genomic Medicine\u00a0 Drug Delivery &amp; Vector Design Clinical Research &amp; Translational Science Biopharma &amp; Manufacturing\u00a0 Investment &amp; Venture Capital\u00a0 Health Policy &amp; Global Health Key Themes and Topics Fundamentals of Flow Chemistry: The conference begins with an exploration of the fundamental principles and concepts underlying flow chemistry, including reactor configurations, reaction kinetics, and key advantages over traditional batch processes. Applications Across Industries: Attendees will gain insights into the diverse applications of flow chemistry across various industries, including pharmaceuticals, fine chemicals, petrochemicals, materials science, and biotechnology. Case studies and success stories will highlight the practical implementation of flow chemistry in real-world manufacturing processes. Advanced Techniques and Innovations: The conference will showcase cuttingedge developments and innovations in flow chemistry techniques, such as flow electrochemistry, flow photochemistry, and flow biocatalysis. Participants will learn about the latest methodologies and technologies pushing the boundaries of chemical synthesis and process optimization. Practical Considerations and Challenges: Practical aspects of flow chemistry, including reactor design, instrumentation, automation, and scalability, will be discussed. Challenges such as regulatory compliance, safety considerations, and integration with existing processes will also be addressed. Sustainability and Green Chemistry: Flow chemistry&#8217;s role in promoting sustainable manufacturing practices and reducing environmental impact will be a central theme. Attendees will explore how flow chemistry enables greener and more efficient chemical processes through reduced waste generation, energy consumption, and solvent usage. Future Directions and Opportunities: The conference will conclude with a forward-looking perspective on the future of flow chemistry, highlighting emerging trends, opportunities for innovation, and potential applications in areas such as continuous manufacturing, personalized medicine, and advanced materials. Day 1 \u2013 Technologies, Tools &amp; Therapeutic Frontiers 09:00 Opening Keynote: The Gene Editing Era Begins From proof-of-concept to patient trials Pioneers in editing: reflections and vision for the future 09:30 Session 1: Emerging Editing Platforms Base and prime editing advances Engineered CRISPR systems and alternatives Specificity, off-target minimization, and control 11:00 Coffee &amp; Networking Break 11:30 Session 2: In Vivo Delivery Innovation AAV, LNP, and new vector systems Tissue specificity and targeting Overcoming innate immunity and biological barriers 01:00 Networking Lunch 02:00 Session 3: Clinical Applications \u2013 Rare Diseases Preclinical to clinical progress in monogenic disorders Case studies: muscular dystrophy, retinal diseases, hemophilia Patient selection, endpoints, and durability 03:30 Session 4: Manufacturing &amp; CMC Strategy Scalable production of gene editors Purity, potency, and release criteria Integrating QC and regulatory compliance 05:00 Panel Discussion: The Road to First Approvals Timeline for the first in vivo gene editing drugs Investor perspectives Readiness of healthcare systems and providers Day 2 \u2013 Translation, Regulation &amp; Global Access 09:00 Session 5: Common Diseases &amp; Regenerative Indications Gene editing for cardiovascular, hepatic, and CNS disorders Regenerative repair and cell in situ reprogramming Early clinical data and pipeline highlights 10:30 Coffee &amp; Networking Break 11:00 Session 6: Immunology, Oncology &amp; Autoimmunity In vivo editing for T cell modulation and cancer Autoimmune disease targeting via epigenetic and genomic reprogramming Combined modality approaches 12:30 Networking Lunch + Poster Session 01:30 Session 7: Ethics, Equity &amp; Global Deployment Ethical considerations in germline vs somatic editing Strategies for affordable, scalable treatments Partnerships for deployment in resource-limited settings 03:00 Session 8: Regulatory &amp; Clinical Translation EMA\/FDA guidance on in vivo editing Long-term follow-up frameworks Real-world evidence and registries 04:30 Closing Panel: Editing the Future of Medicine What&#8217;s next in platform convergence Sustainable investment and infrastructure Vision for 2030: Universal access to gene correction Events draft Events Multi-Omics Drug Discovery &#038; Development Conference Transforming Drug Development with Deep Multi-Omics Insights Multi-Omics Drug Discovery &amp; Development Conference From Data Layers to Therapeutic Breakthroughs Speak, draft Events Advanced Therapy Medicinal Products Conference Shaping the Future of Regenerative Medicine and Advanced Therapeutics Advanced Therapy Medicinal Products Conference Engineering the Future of Medicine \u2014 draft Events AI Safety &#038; Ethics Barcelona Summit 2025 AI Safety &amp; Ethics Barcelona Summit 2025 Welcome to the AI Safety &amp; Ethics Barcelona Summit 2025 &#8211; The AI draft Events Targeted Protein Degradation Barcelona Summit 2025 Join global leaders in TPD, degrader development, and E3 ligase biology for two days of insight, innovation, and partnering. Targeted draft Events Reinsurance Barcelona Summit 2026 Reinsurance Barcelona Summit 2026 Welcome to"}